Relationship between xanthine oxidase gene polymorphisms and anti-tuberculosis drug-induced liver injury in a Chinese population

被引:4
|
作者
Ai, Xin [1 ]
Huang, Hangxing [1 ]
Miao, Zhimin [1 ]
Zhou, Tao [1 ]
Wu, He [1 ]
Lai, Yong [1 ]
机构
[1] Dali Univ, Coll Pharm, Dept Pharmacol, 32 Jia Shi Bo Ave, Dali 671000, Yunnan, Peoples R China
关键词
Anti-tuberculosis drug; Liver injury; Genetic  polymorphism; Xanthine oxidase; Drug metabolizing enzymes; INDUCED HEPATOTOXICITY; N-ACETYLTRANSFERASE-2; GENE; MOLECULAR-CLONING; ADVERSE EVENTS; RISK-FACTORS; PYRAZINAMIDE; ASSOCIATION; METABOLITES; EXPRESSION; HEPATITIS;
D O I
10.1016/j.meegid.2021.104991
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
This study was designed to investigate the association of the xanthine oxidase (XO) polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury (ATDILI) in Chinese population. A total of 183 tuberculosis patients were enrolled. Patients with ATDILI were classified as cases and those without ATDILI were classified as controls. Genotyping for XO polymorphisms was determined by polymerase chain reaction and direct sequencing. The allele frequencies and genotype distribution was analyzed using the Chi square test to analyze the association between the gene polymorphisms and ATDILI. Binary logistic regression analysis was performed to assess the risk factors of ATDILI. A total of 21 patients were developed liver injury during antituberculosis treatment in this study, with an incidence of 11.48%. In genotype analysis, no significant difference was observed in the alleles and genotypes frequencies of the six SNPs between two groups (P 0.05). In haplotype analysis, carriers with GGGATA (rs1884725- rs2295475 -rs45523133- rs206812- rs206813rs7575607) haplotype had a significantly higher risk of ATDILI compared with other haplotypes (OR = 2.445, 95%CI: 1.058-5.652, P < 0.05). This study suggested that the haplotype GGGATA constructed with rs206812 and rs7575607 mutant alleles might contribute to ATDILI susceptibility in a Chinese population.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Absence of significant association betweenUGT2B4genetic variants and the susceptibility to anti-tuberculosis drug-induced liver injury in a Western Chinese population
    Chen, Hao
    Jiao, Lin
    Zhou, Juan
    Bai, Hao
    Lyu, Mengyuan
    Wu, Tao
    Wu, Lijuan
    Song, Jiajia
    Liu, Tangyuheng
    Yan, Hong
    Ying, Binwu
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (01) : 66 - 73
  • [22] The role of NAT2 polymorphism and methylation in anti-tuberculosis drug-induced liver injury in Mongolian tuberculosis patients
    Zhang, Dong
    Hao, Jinqi
    Hou, Ruili
    Yu, Yanqin
    Hu, Baocui
    Wei, Liqin
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 (03) : 561 - 569
  • [23] Cytochrome P450 2E1 Gene Polymorphisms/Haplotypes and Anti-Tuberculosis Drug-Induced Hepatitis in a Chinese Cohort
    Tang, Shaowen
    Lv, Xiaozhen
    Zhang, Yuan
    Wu, Shanshan
    Yang, Zhirong
    Xia, Yinyin
    Tu, Dehua
    Deng, Peiyuan
    Ma, Yu
    Chen, Dafang
    Zhan, Siyan
    PLOS ONE, 2013, 8 (02):
  • [24] Genetic polymorphisms in PXR and NF-κB1 influence susceptibility to anti-tuberculosis drug-induced liver injury
    Zhang, Jingwei
    Zhao, Zhenzhen
    Bai, Hao
    Wang, Minjin
    Jiao, Lin
    Peng, Wu
    Wu, Tao
    Liu, Tangyuheng
    Chen, Hao
    Song, Xingbo
    Wu, Lijuan
    Hu, Xuejiao
    Wu, Qian
    Zhou, Juan
    Song, Jiajia
    Lyv, Mengyuan
    Ying, Binwu
    PLOS ONE, 2019, 14 (09):
  • [25] Incidence, Clinical Features and Impact on Anti-Tuberculosis Treatment of Anti-Tuberculosis Drug Induced Liver Injury (ATLI) in China
    Shang, Penghui
    Xia, Yinyin
    Liu, Feiying
    Wang, Xiaomeng
    Yuan, Yanli
    Hu, Daiyu
    Tu, Dehua
    Chen, Yixin
    Deng, Peiyuan
    Cheng, Shiming
    Zhou, Lin
    Ma, Yu
    Zhu, Lizhen
    Gao, Weiwei
    Wang, Hongyuan
    Chen, Dafang
    Yang, Li
    He, Pingping
    Wu, Shanshan
    Tang, Shaowen
    Lv, Xiaozhen
    Shu, Zheng
    Zhang, Yuan
    Yang, Zhirong
    Chen, Yan
    Li, Na
    Sun, Feng
    Li, Xiaoting
    He, Yingjian
    Garner, Paul
    Zhan, Siyan
    PLOS ONE, 2011, 6 (07):
  • [26] TANC1 methylation as a novel biomarker for the diagnosis of patients with anti-tuberculosis drug-induced liver injury
    Wu, Dongxue
    Li, Yuhong
    Ren, Qi
    Pei, Shengfei
    Wang, Lin
    Yang, Luming
    Chong, Yingzhi
    Sun, Shufeng
    Hao, Jinqi
    Feng, Fumin
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [27] NAT2 variants are associated with drug-induced liver injury caused by anti-tuberculosis drugs in Indonesian patients with tuberculosis
    Yuliwulandari, Rika
    Susilowati, Retno Wilujeng
    Wicaksono, Britanto Dani
    Viyati, Kencono
    Prayuni, Kinasih
    Razari, Intan
    Kristin, Erna
    Syafrizal
    Subagyo
    Diana, Eva Sri
    Setiawati, Suci
    Ariyani, Aziza
    Mahasirimongkol, Surakameth
    Yanai, Hideki
    Mushiroda, Taisei
    Tokunaga, Katsushi
    JOURNAL OF HUMAN GENETICS, 2016, 61 (06) : 533 - 537
  • [28] The role of cigarette smoking and liver enzymes polymorphisms in anti-tuberculosis drug-induced hepatotoxicity in Brazilian patients
    Zaverucha-do-Valle, Camila
    Monteiro, Sergio P.
    El-Jaick, Kenia B.
    Rosadas, Leonardo A.
    Costa, Marli J. M.
    Quintana, Marcel S. B.
    de Castro, Liane
    TUBERCULOSIS, 2014, 94 (03) : 299 - 305
  • [29] A prospective study on associations between superoxide dismutase gene polymorphisms and antituberculosis drug-induced liver injury in a Chinese Han population
    Wu, Tao
    Bai, Hao
    Zhao, Zhenzhen
    Wang, Minjin
    Hu, Xuejiao
    Jiao, Lin
    Wu, Qian
    Liu, Tangyuheng
    Zhang, Chunying
    Chen, Hao
    Zhang, Jingwei
    Song, Jiajia
    Wu, Lijuan
    Zhou, Wenjing
    Tong, Chongxiang
    Ying, Binwu
    JOURNAL OF GENE MEDICINE, 2019, 21 (10)
  • [30] Anti-Tuberculosis Drug-Induced Liver Injury in Shanghai: Validation of Hy’s Law
    Xin Shen
    Zheng’an Yuan
    Jian Mei
    Zurong Zhang
    Juntao Guo
    Zheyuan Wu
    Jie Wu
    Haihua Zhang
    Jieping Pan
    Wenming Huang
    Huili Gong
    Dong Yuan
    Ping Xiao
    Yanqin Wang
    Yi Shuai
    Senlin Lin
    Qichao Pan
    Tong Zhou
    Paul B. Watkins
    Fan Wu
    Drug Safety, 2014, 37 : 43 - 51